ArticlePloS one2025

Molecular docking and MD simulations predicted quercetin as a potent human interleukin-1 beta (hIL1β) inhibitor for improved endodontic disease management.

Nezar Boreak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.